Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Filings indexed 1,778 across all filing types
Latest filing 2015-12-01 Governance Information
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
Declaration of Compliance with the German Corporate Governance Code for the year 2015
Governance Information Classification · 98% confidence The document is explicitly titled 'Declaration of Compliance with the German Corporate Governance Code for the year 2015'. It details the company's adherence (or exceptions to adherence) to the German Corporate Governance Code, referencing specific sections of the code and decisions made by the Management Board and Supervisory Board. This content directly relates to the company's internal rules, board structure, and governance practices, matching the definition for Governance Information (CGR). The document length is relatively short (3090 chars), but it is the report itself, not an announcement of a report's publication.
2015-12-01 English
Entsprechenserklärung zum Deutschen Corporate Governance Kodex für das Jahr 2015
Governance Information Classification · 99% confidence The document title is "Entsprechenserklärung zum Deutschen Corporate Governance Kodex für das Jahr 2015" (Declaration of Conformity with the German Corporate Governance Code for the Year 2015). The text explicitly discusses compliance, exceptions, and adherence to the German Corporate Governance Code (Kodex) regarding board structure, management compensation (D&O insurance, variable pay), and shareholder interests. This content directly relates to the company's internal rules, board structure, and governance practices. Therefore, the appropriate classification is Governance Information (CGR). The document is a formal declaration, not a general announcement of a report (RPA) or a miscellaneous filing (RNS).
2015-12-01 German
Evotec AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Total Voting Rights Announcement' and explicitly states the total number of voting rights as of November 30, 2015, referencing Article 26a of the WpHG (German Securities Trading Act). This type of announcement, which reports on the total number of shares or voting rights outstanding, is not explicitly covered by the primary definitions (like 10-K, ER, or DIV). However, it is a specific regulatory disclosure concerning the capital structure or shareholder rights. Since it is not a declaration of voting *results* (DVA) but a statement of the *total rights* available, and given its nature as a mandatory regulatory disclosure that doesn't fit other specific categories, it is best classified under the general 'Regulatory Filings' (RNS) category, which serves as the fallback for miscellaneous regulatory announcements.
2015-11-30 English
Evotec AG: Release of the Home Member State according to Article 2c of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Regulatory Filings Classification · 95% confidence The document is very short (1222 characters) and its primary function is to announce a regulatory status update: the designation of Germany as the 'Home Member State' according to Article 2c of the WpHG (German Securities Trading Act). It explicitly states it is a 'Post-admission Duties announcement' transmitted by DGAP. This type of general regulatory notification that doesn't fit into specific categories like Earnings Release (ER), Director's Dealing (DIRS), or Capital Change (CAP) is best classified under the general regulatory filing category.
2015-11-26 English
Jefferies 2015 Global Healthcare Conference
Investor Presentation Classification · 98% confidence The document is titled 'Evotec Company presentation, Jefferies 2015 Global Healthcare Conference, 18 November 2015, London'. It contains slides, an agenda, forward-looking statements, detailed pipeline information, and condensed segment financial data for the first nine months of 2015. This structure is characteristic of an Investor Presentation (IP) given at a conference, rather than a formal regulatory filing like a 10-K or an Earnings Release (ER). It is a presentation designed to convey strategy, pipeline progress, and financial highlights to investors.
2015-11-18 English
Interim / Quarterly Report 2015
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Evotec AG, Nine-month 2015 Interim Report' and contains detailed financial statements, income statements, and operational performance analysis for the nine-month period ending 30 September 2015. It is clearly a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2015
2015-11-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.